Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $9.27 in the prior trading day, Capricor Therapeutics Inc (NASDAQ: CAPR) closed at $9.06, down -2.27%. In other words, the price has decreased by -$2.27 from its previous closing price. On the day, 1.94 million shares were traded. CAPR stock price reached its highest trading level at $9.26 during the session, while it also had its lowest trading level at $8.33.
Ratios:
Our goal is to gain a better understanding of CAPR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.77 and its Current Ratio is at 7.77. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on October 21, 2024, initiated with a Overweight rating and assigned the stock a target price of $35.
On May 17, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $14.
On January 05, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.Cantor Fitzgerald initiated its Overweight rating on January 05, 2024, with a $8 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 20 ’24 when Nippon Shinyaku Co Ltd bought 2,798,507 shares for $5.36 per share. The transaction valued at 14,999,998 led to the insider holds 7,090,351 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAPR now has a Market Capitalization of 413826400 and an Enterprise Value of 263761632. For the stock, the TTM Price-to-Sale (P/S) ratio is 18.58 while its Price-to-Book (P/B) ratio in mrq is 2.84. Its current Enterprise Value per Revenue stands at 11.844 whereas that against EBITDA is -6.411.
Stock Price History:
The Beta on a monthly basis for CAPR is 0.92, which has changed by 0.37689972 over the last 52 weeks, in comparison to a change of -0.024663687 over the same period for the S&P500. Over the past 52 weeks, CAPR has reached a high of $23.40, while it has fallen to a 52-week low of $3.52. The 50-Day Moving Average of the stock is -32.79%, while the 200-Day Moving Average is calculated to be -22.77%.
Shares Statistics:
The stock has traded on average 1.21M shares per day over the past 3-months and 1555120 shares per day over the last 10 days, according to various share statistics. A total of 45.58M shares are outstanding, with a floating share count of 40.12M. Insiders hold about 12.16% of the company’s shares, while institutions hold 38.85% stake in the company. Shares short for CAPR as of 1741910400 were 9072729 with a Short Ratio of 7.51, compared to 1739491200 on 8160363. Therefore, it implies a Short% of Shares Outstanding of 9072729 and a Short% of Float of 24.299999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
